PIIND2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2020-04-012020-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PIIND 2020-04-01 2021-03-31 2020-07-16 INR Millions First quarter Single segment Agri 2020-04-01 2020-06-30 Unaudited Consolidated 10601000000.00 82000000.00 10683000000.00 5280000000.00 845000000.00 21000000.00 991000000.00 96000000.00 427000000.00 1172000000.00 8832000000.00 1851000000.00 0.00 1851000000.00 275000000.00 169000000.00 444000000.00 0.00 1407000000.00 0.00 0.00 0.00 48000000.00 1455000000.00 242000000.00 1697000000.00 1697000000.00 0.00 1697000000.00 0.00 138000000.00 1 10.52 10.52 0.00 0.00 10.52 10.52 1.The above Consolidated financial results were reviewed and recommended by the Audit Committee approved by the Board of Directors at the meeting held on 04.08.2020.2.Consolidated Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time.3.The Consolidated financial results include the results of the following entities namely, Subsidiaries a) PILL Finance and Investment Limited b) PI Life Science Research Limited c) PI Japan Co. Limited d) Isagro (Asia) Agrochemicals Private Limited e) Jivagro Limited¿ ¿f) PI ESOP Trust; Equity accounted entities: g) PI Kumiai Private Limited (Joint Venture) h) Solinnos Agro Sciences Private Limited (Associate).4.The figures for the quarter ended 31.03.2020 are the balancing figures between audited figures for the financial year ending 31.03.2020¿and the published unaudited figures for nine months period ended 31.12.2019.5.The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. 'Agro Chemicals'.6. Post the nationwide lockdown announced on 24.03.2020 and resumption of operations during April 2020 as the Group is dealing in essential commodity, management believes that there is no significant impact of COVID-19 pandemic on the current and future business condition of the Group, liquidity position and cash flow and has concluded that no material adjustments are required in the financial statements. Management will continue to closely monitor the situation.¿6. The Company has raised to Rs. 20,000 million in July 2020 through QIP and issued 1,36,05,442 Equity shares of face value Re 1, price rs 1470 per equity share, including premium of Rs. 1469.7. The previous period's figures have been regrouped/reclassified/rearranged wherever necessary.